R S Choung1, G Richard Locke1, C D Schleck2, A R Zinsmeister2, N J Talley3. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. 2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. 3. Faculty of Health and Medicine, University of Newcastle, New Lambton, NSW, Australia.
Abstract
BACKGROUND: It is unknown why functional gastrointestinal disorders (FGIDs) overlap and limited information exists on risk factors for those with overlap. Our aim was to estimate the prevalence of combinations of FGIDs including reflux (FGIDs-gastroesophageal reflux [GER]), and evaluate potential risk factors for people with multiple disorders in a representative US community. METHODS: A population-based study was conducted by mailing a valid GI symptom questionnaire to an age- and gender-stratified random sample of residents of Olmsted County, MN. Rome III definitions were used to identify people with FGIDs, and GER was defined by weekly or more frequent heartburn or acid regurgitation. The prevalence of people meeting multiple symptom complexes was estimated. Moreover, potential risk factors for people with multiple disorders were evaluated. KEY RESULTS: A total of 3548 people provided data for each of the necessary symptom questions (mean age: 61±16 years, 54% female). Among these 3548 subjects, 2009 (57%) had no FGIDs-GER, 906 (26%) had a pure FGID-GER, 372 (10%) had 2 FGIDs-GER, and 261 (7%) had 3 or more FGIDs-GER. Somatization as assessed by a higher Somatic Symptom Checklist score (OR=3.3, 95% CI [2.7,4.1]) was associated with an increased odds for those with 3 or more FGIDs-GER compared to subjects with a pure FGID-GER adjusting for age and gender. CONCLUSIONS AND INFERENCES: Symptom complex overlap is common rather than rare in the community. GER is an integral symptom complex associated with both upper and lower FGIDs. Somatization is a strong risk factor for multiple FGIDs.
BACKGROUND: It is unknown why functional gastrointestinal disorders (FGIDs) overlap and limited information exists on risk factors for those with overlap. Our aim was to estimate the prevalence of combinations of FGIDs including reflux (FGIDs-gastroesophageal reflux [GER]), and evaluate potential risk factors for people with multiple disorders in a representative US community. METHODS: A population-based study was conducted by mailing a valid GI symptom questionnaire to an age- and gender-stratified random sample of residents of Olmsted County, MN. Rome III definitions were used to identify people with FGIDs, and GER was defined by weekly or more frequent heartburn or acid regurgitation. The prevalence of people meeting multiple symptom complexes was estimated. Moreover, potential risk factors for people with multiple disorders were evaluated. KEY RESULTS: A total of 3548 people provided data for each of the necessary symptom questions (mean age: 61±16 years, 54% female). Among these 3548 subjects, 2009 (57%) had no FGIDs-GER, 906 (26%) had a pure FGID-GER, 372 (10%) had 2 FGIDs-GER, and 261 (7%) had 3 or more FGIDs-GER. Somatization as assessed by a higher Somatic Symptom Checklist score (OR=3.3, 95% CI [2.7,4.1]) was associated with an increased odds for those with 3 or more FGIDs-GER compared to subjects with a pure FGID-GER adjusting for age and gender. CONCLUSIONS AND INFERENCES: Symptom complex overlap is common rather than rare in the community. GER is an integral symptom complex associated with both upper and lower FGIDs. Somatization is a strong risk factor for multiple FGIDs.
Authors: William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash Journal: Am J Gastroenterol Date: 2010-02-23 Impact factor: 10.864
Authors: Thierry Piche; Stanislas Bruley des Varannes; Sylvie Sacher-Huvelin; Jens Juul Holst; Jean Claude Cuber; Jean Paul Galmiche Journal: Gastroenterology Date: 2003-04 Impact factor: 22.682
Authors: Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter Journal: Gastroenterology Date: 2011-11-19 Impact factor: 22.682
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Am J Epidemiol Date: 2011-03-23 Impact factor: 4.897
Authors: Imran Aziz; Olafur S Palsson; Hans Törnblom; Ami D Sperber; William E Whitehead; Magnus Simrén Journal: Am J Gastroenterol Date: 2017-11-14 Impact factor: 10.864
Authors: Axel Josefsson; Olafur Palsson; Magnus Simrén; Ami D Sperber; Hans Törnblom; William Whitehead Journal: United European Gastroenterol J Date: 2018-09-06 Impact factor: 4.623
Authors: Rok Seon Choung; Abhinav Lamba; Eric V Marietta; Jacalyn A See; Joseph J Larson; Katherine S King; Carol T Van Dyke; Alberto Rubio-Tapia; Joseph A Murray Journal: J Clin Gastroenterol Date: 2020-08 Impact factor: 3.174
Authors: A Pali S Hungin; Carmelo Scarpignato; Laurie Keefer; Maura Corsetti; Foteini Anastasiou; Jean W M Muris; Juan M Mendive; Peter J Kahrilas Journal: Aliment Pharmacol Ther Date: 2022-04-22 Impact factor: 9.524
Authors: Rok Seon Choung; Yuri A Saito; Cathy D Schleck; William S Harmsen; Alan R Zinsmeister; Joseph A Murray; Nicholas J Talley Journal: Mayo Clin Proc Date: 2021-03 Impact factor: 11.104
Authors: Nuno Ferreira; Antonina Mikocka-Walus; Miranda A L van Tilburg; Lesley A Graff; Pragalathan Apputhurai; Manuel Barreiro-de Acosta; Floor Bennebroek Evertsz; Johan Burisch; Bobby Lo; Megan Petrik; Inês A Trindade; Sharon Jedel; Gabriele Moser; Anna Mokrowiecka; Charles N Bernstein; Dan Dumitrascu; Alexander C Ford; Andreas Stengel; Richard Gearry; Simon R Knowles Journal: J Psychosom Res Date: 2021-06-29 Impact factor: 3.006